Alzheimer’s Memory Loss Reversed by New Head Device Using Electromagnetic Waves

New results indicate that in-home treatment with a bioengineered head device emitting electromagnetic waves reversed memory impairment of Alzheimer’s patients

September 17, 2019 - Phoenix, AZ, USA – There is finally some encouraging news for the millions of Americans suffering from Alzheimer’s disease. NeuroEM Therapeutics today announced findings from an open label clinical trial showing reversal of cognitive impairment in Alzheimer’s Disease patients after just two months of treatment using the company’s wearable head device for in-home treatment. Results demonstrate that TEMT was safe in all eight participating patients with mild to moderate AD and enhanced cognitive performance in seven of them, as measured by their ADAS-cog score, which is the benchmark for testing AD therapeutics. The open access study is published in the new issue of the Journal of Alzheimer’s Disease. More...

September 17, 2019

Exercise Could Slow Withering Effects of Alzheimer’s

September 17, 2019 - Dallas, TX, USA – Exercising several times a week may delay brain deterioration in people at high risk for Alzheimer’s disease, according to a study that scientists say merits further research to establish whether fitness can affect the progression of dementia. Research from UT Southwestern found that people who had accumulation of amyloid beta in the brain – a hallmark of Alzheimer’s disease – experienced slower degeneration in a region of the brain crucial for memory if they exercised regularly for one year. More...

September 17, 2019

New Insights: Dementia, Risk, Risk Reduction, and Translation into Practice

Noted experts report on the latest research into potential risk factors for dementia and how to reduce these risks in this open access JAD supplement from IRNDP

September 3, 2019 - Amsterdam, NL – Globally, dementia cases are increasing at a rate of more than 20% a year. Most of these cases are in low- to middle-income countries. In an open access to the Journal of Alzheimer’s Disease, from the International Research Network on Dementia Prevention (IRNDP), an international group of scientists presents new research from around the world examining the potential risk factors for dementia and how to reduce them. More...

September 3, 2019

Fatigue in Parkinson’s Disease Is Associated with Lower Diastolic Blood Pressure

In a novel research study published in JPD, investigators found that fatigue symptoms in Parkinson’s disease are associated with low diastolic blood pressure, paving the way for developing targeted treatments

August 22, 2019 - Amsterdam, NL – Fatigue is a common debilitating symptom in Parkinson's disease (PD). A novel research study has found that fatigue symptoms in PD are associated with small but persistent reductions in diastolic blood pressure (DBP) throughout the day, report scientists in the Journal of Parkinson's Disease. More...

August 22, 2019